| scholarly article | Q13442814 |
| P50 | author | Deborah Mash | Q545893 |
| Alessandro Stefani | Q56418196 | ||
| Irwin J Kopin | Q85857575 | ||
| P2093 | author name string | Ellen Sidransky | |
| David S Goldstein | |||
| Patti Sullivan | |||
| Courtney Holmes | |||
| Yehonatan Sharabi | |||
| P2860 | cites work | Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease | Q49046932 |
| Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[18F]fluorodopamine: initial findings in humans | Q58855454 | ||
| Cardiac sympathetic denervation in Parkinson disease | Q64769188 | ||
| Postmortem findings in primary familial amyloidosis with polyneuropathy | Q66963843 | ||
| Cardiac sympathetic denervation in transthyretin-related familial amyloidotic polyneuropathy: detection with iodine-123-MIBG | Q72284009 | ||
| Accumulation of alpha-synuclein in autonomic nerves in pure autonomic failure | Q73733365 | ||
| Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy | Q78143296 | ||
| Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy | Q79335110 | ||
| Neuropharmacologic distinction of neurogenic orthostatic hypotension syndromes | Q83987525 | ||
| Peripheral autonomic nervous system involvement in Gaucher-related parkinsonism | Q87049176 | ||
| Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia | Q24536194 | ||
| Second consensus statement on the diagnosis of multiple system atrophy | Q24650965 | ||
| Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders | Q26826093 | ||
| Parkinsonian syndromes | Q27007524 | ||
| Mutation in the alpha-synuclein gene identified in families with Parkinson's disease | Q27860459 | ||
| alpha-Synuclein locus triplication causes Parkinson's disease | Q27860533 | ||
| Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease | Q48173071 | ||
| Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease | Q48245306 | ||
| Biochemical pathophysiology of Parkinson's disease. | Q48258284 | ||
| Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum | Q48301354 | ||
| 6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods | Q48366038 | ||
| Parkinsonism in type I Gaucher's disease | Q48369692 | ||
| PET measurement of cardiac and nigrostriatal denervation in Parkinsonian syndromes. | Q48380748 | ||
| Glucocerebrosidase mutations are an important risk factor for Lewy body disorders | Q48491146 | ||
| Differentiating between multiple system atrophy and Parkinson's disease by positron emission tomography with 18F-dopa and 18F-FDG. | Q48641864 | ||
| Brain monoamine systems in multiple system atrophy: a positron emission tomography study. | Q48698262 | ||
| Urinary catecholamine metabolites distinguish different types of sympathetic neuronal dysfunction in patients with orthostatic hypotension | Q48740724 | ||
| Vesicular uptake blockade generates the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde in PC12 cells: relevance to the pathogenesis of Parkinson's disease | Q36445937 | ||
| The serotonin aldehyde, 5-HIAL, oligomerizes alpha-synuclein | Q36585538 | ||
| Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy | Q37114685 | ||
| Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis | Q37544921 | ||
| Plasma catechols in familial dysautonomia: a long-term follow-up study | Q37590357 | ||
| Cardiac sympathetic hypo-innervation in familial dysautonomia | Q37594601 | ||
| Plasma biomarkers of decreased vesicular storage distinguish Parkinson disease with orthostatic hypotension from the parkinsonian form of multiple system atrophy | Q37595850 | ||
| The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease | Q37646362 | ||
| Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis | Q37957562 | ||
| Parkinson's disease and parkinsonism: neuropathology | Q38036232 | ||
| Incidental Lewy body disease and preclinical Parkinson disease | Q38425396 | ||
| Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels | Q39113010 | ||
| The pathochemical perspectives of Parkinson's disease. An attempt at a neurochemical definition. | Q39571775 | ||
| Dopamine (DA) induced irreversible proteasome inhibition via DA derived quinones | Q39871971 | ||
| Mechanism of DNA damage and apoptosis induced by tetrahydropapaveroline, a metabolite of dopamine | Q40270737 | ||
| Positron emission imaging of cardiac sympathetic innervation and function using 18F-6-fluorodopamine: effects of chemical sympathectomy by 6-hydroxydopamine. | Q41130007 | ||
| The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature | Q41561097 | ||
| Protein reactivity of 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite, is dependent on both the aldehyde and the catechol | Q41786059 | ||
| Cardiac sympathetic denervation without Lewy bodies in a case of multiple system atrophy | Q42060109 | ||
| Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo | Q42467775 | ||
| Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation | Q42501526 | ||
| Sympathetic cardiac denervation in Parkinson's disease and pure autonomic failure but not in multiple system atrophy | Q43045054 | ||
| Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation | Q43244813 | ||
| 3,4-Dihydroxyphenylacetaldehyde and hydrogen peroxide generate a hydroxyl radical: possible role in Parkinson's disease pathogenesis | Q43725921 | ||
| Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSA. | Q43747031 | ||
| Kinetic model for the fate of 6-[18F]fluorodopamine in the human heart: a novel means to examine cardiac sympathetic neuronal function | Q43893823 | ||
| Cerebral metabolic changes in early multiple system atrophy: a PET study | Q44071363 | ||
| Fate of tritiated 6-fluorodopamine in rats: a false neurotransmitter for positron emission tomographic imaging of sympathetic innervation and function. | Q44152883 | ||
| Pandysautonomia associated with impaired ganglionic neurotransmission and circulating antibody to the neuronal nicotinic receptor | Q44161533 | ||
| Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy | Q44335070 | ||
| Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication | Q44737169 | ||
| Accuracy of clinical diagnosis in parkinsonism--a prospective study | Q45181774 | ||
| Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease | Q45346135 | ||
| Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls. | Q46011395 | ||
| Profound cardiac sympathetic denervation occurs in Parkinson disease | Q46392026 | ||
| Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease | Q46525821 | ||
| Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease | Q46622448 | ||
| Central dopamine deficiency in pure autonomic failure | Q46685407 | ||
| Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice | Q46815723 | ||
| Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease | Q46900351 | ||
| Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study | Q46988378 | ||
| Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy | Q47772222 | ||
| Nigrostriatal overabundance of α-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity. | Q48006941 | ||
| Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications | Q48088787 | ||
| Neurocirculatory and nigrostriatal abnormalities in Parkinson disease from LRRK2 mutation | Q48108282 | ||
| Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease | Q48127846 | ||
| ??? | Q64865235 | ||
| Alpha-synuclein in Lewy bodies | Q27860680 | ||
| Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency | Q28145295 | ||
| Brain dopamine-serotonin vesicular transport disease and its treatment | Q28284572 | ||
| Relation of plasma norepinephrine and sympathetic traffic during hypotension in humans | Q28334771 | ||
| Increase in dopamine turnover occurs early in Parkinson's disease: evidence from a new modeling approach to PET 18 F-fluorodopa data | Q30671310 | ||
| Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes | Q33148235 | ||
| Orthostatic hypotension in familial amyloid polyneuropathy: treatment with DL-threo-3,4-dihydroxyphenylserine | Q33172294 | ||
| Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data | Q33226682 | ||
| Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine | Q33344779 | ||
| Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus | Q33724885 | ||
| Divalent metal ions enhance DOPAL-induced oligomerization of alpha-synuclein. | Q33771253 | ||
| Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease | Q33896138 | ||
| The neuropathic postural tachycardia syndrome | Q33920200 | ||
| Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome. | Q33985907 | ||
| Hypertension increases cerebral 6-18F-fluorodopa-derived radioactivity | Q34182833 | ||
| Clinical laboratory evaluation of autoimmune autonomic ganglionopathy: Preliminary observations | Q34182853 | ||
| Intracellular patch electrochemistry: regulation of cytosolic catecholamines in chromaffin cells. | Q34211646 | ||
| Cardiac sympathetic neuroimaging: summary of the First International Symposium | Q34235882 | ||
| Partial cardiac sympathetic denervation after bilateral thoracic sympathectomy in humans | Q34422109 | ||
| Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). | Q34458365 | ||
| A vesicular sequestration to oxidative deamination shift in myocardial sympathetic nerves in Parkinson's disease | Q34560077 | ||
| In vivo demonstration that alpha-synuclein oligomers are toxic | Q34652122 | ||
| Characterization of reduced and oxidized dopamine and 3,4-dihydrophenylacetic acid, on brain mitochondrial electron transport chain activities | Q35024921 | ||
| Oxidation of 3,4-dihydroxyphenylacetaldehyde, a toxic dopaminergic metabolite, to a semiquinone radical and an ortho-quinone. | Q35128313 | ||
| Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases | Q35142854 | ||
| (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease | Q35452165 | ||
| Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy | Q35638948 | ||
| Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons | Q35807528 | ||
| Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies | Q35986671 | ||
| Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease | Q36063269 | ||
| Catechols in post-mortem brain of patients with Parkinson disease | Q36086433 | ||
| Sympathetic neurocirculatory failure in Parkinson disease: Evidence for an etiologic role of alpha-synuclein | Q36100326 | ||
| The neurobiology of glucocerebrosidase-associated parkinsonism: a positron emission tomography study of dopamine synthesis and regional cerebral blood flow | Q36124421 | ||
| P433 | issue | 9 | |
| P921 | main subject | neurodegeneration | Q1755122 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 1013-1022 | |
| P577 | publication date | 2015-07-17 | |
| P1433 | published in | Parkinsonism and Related Disorders | Q15762600 |
| P1476 | title | Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration | |
| P478 | volume | 21 |
| Q91862580 | Alpha-Synuclein Deposition Within Sympathetic Noradrenergic Neurons Is Associated With Myocardial Noradrenergic Deficiency in Neurogenic Orthostatic Hypotension |
| Q99566885 | Cardiac sympathetic innervation and vesicular storage in pure autonomic failure |
| Q92118440 | Computational modeling reveals multiple abnormalities of myocardial noradrenergic function in Lewy body diseases |
| Q47377298 | Does sympathetic dysfunction occur before denervation in pure autonomic failure? |
| Q41655727 | Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies |
| Q41927560 | Genetic elimination of dopamine vesicular stocks in the nigrostriatal pathway replicates Parkinson's disease motor symptoms without neuronal degeneration in adult mice. |
| Q64859931 | Imaging the Autonomic Nervous System in Parkinson's Disease |
| Q96953378 | Increased Noradrenaline as an Additional Cerebrospinal Fluid Biomarker in PSP-Like Parkinsonism |
| Q39294770 | Linking Stress, Catecholamine Autotoxicity, and Allostatic Load with Neurodegenerative Diseases: A Focused Review in Memory of Richard Kvetnansky |
| Q48313756 | Pure autonomic failure without synucleinopathy |
| Q49490658 | Tyrosine Hydroxylase, Vesicular Monoamine Transporter and Dopamine Transporter mRNA Expression in Nigrostriatal Tissue of Rats with Pedunculopontine Neurotoxic Lesion |
Search more.